<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">84315</article-id><article-id pub-id-type="doi">10.7554/eLife.84315</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Epidemiology and Global Health</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group></article-categories><title-group><article-title>A meta-analysis of genome-wide association studies of childhood wheezing phenotypes identifies <italic>ANXA1</italic> as a susceptibility locus for persistent wheezing</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-296286"><name><surname>Granell</surname><given-names>Raquel</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4890-4012</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-300365"><name><surname>Curtin</surname><given-names>John A</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-300366"><name><surname>Haider</surname><given-names>Sadia</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-300367"><name><surname>Kitaba</surname><given-names>Negusse Tadesse</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7518-9096</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-300368"><name><surname>Mathie</surname><given-names>Sara A</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-300369"><name><surname>Gregory</surname><given-names>Lisa G</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-300370"><name><surname>Yates</surname><given-names>Laura L</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-300371"><name><surname>Tutino</surname><given-names>Mauro</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-300372"><name><surname>Hankinson</surname><given-names>Jenny</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-221146"><name><surname>Perretti</surname><given-names>Mauro</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2068-3331</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-300373"><name><surname>Vonk</surname><given-names>Judith M</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-300374"><name><surname>Arshad</surname><given-names>Hasan S</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-300375"><name><surname>Cullinan</surname><given-names>Paul</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-300376"><name><surname>Fontanella</surname><given-names>Sara</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-300377"><name><surname>Roberts</surname><given-names>Graham C</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-300378"><name><surname>Koppelman</surname><given-names>Gerard H</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-107281"><name><surname>Simpson</surname><given-names>Angela</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-300379"><name><surname>Turner</surname><given-names>Steve W</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-300380"><name><surname>Murray</surname><given-names>Clare S</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf5"/></contrib><contrib contrib-type="author" id="author-166448"><name><surname>Lloyd</surname><given-names>Clare M</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf6"/></contrib><contrib contrib-type="author" id="author-241532"><name><surname>Holloway</surname><given-names>John W</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9998-0464</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf7"/></contrib><contrib contrib-type="author" corresp="yes" id="author-107282"><name><surname>Custovic</surname><given-names>Adnan</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5218-7071</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf8"/></contrib><on-behalf-of>on behalf of UNICORN and Breathing Together Investigators</on-behalf-of><aff id="aff1"><institution content-type="dept">Department of Population Health Sciences</institution>, <institution>University of Bristol</institution>, <addr-line><named-content content-type="city">Bristol</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff2"><institution content-type="dept">Division of Infection, Immunity and Respiratory Medicine</institution>, <institution>University of Manchester</institution>, <addr-line><named-content content-type="city">Manchester</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff3"><institution content-type="dept">National Heart and Lung Institute</institution>, <institution>Imperial College London</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff4"><institution content-type="dept">Faculty of Medicine</institution>, <institution>University of Southampton</institution>, <addr-line><named-content content-type="city">Southampton</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff5"><institution content-type="dept">William Harvey Research Institute</institution>, <institution>Queen Mary University of London</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff6"><institution content-type="dept">Department of Epidemiology</institution>, <institution>University of Groningen</institution>, <addr-line><named-content content-type="city">Groningen</named-content></addr-line>, <country>Netherlands</country></aff><aff id="aff7"><institution>David Hide Asthma and Allergy Research Centre</institution>, <addr-line><named-content content-type="city">Isle of Wight</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff8"><institution content-type="dept">Groningen Research Institute for Asthma and COPD</institution>, <institution>University of Groningen</institution>, <addr-line><named-content content-type="city">Groningen</named-content></addr-line>, <country>Netherlands</country></aff><aff id="aff9"><institution content-type="dept">Child Health</institution>, <institution>University of Aberdeen</institution>, <addr-line><named-content content-type="city">Aberdeeen</named-content></addr-line>, <country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-71518"><name><surname>Agrawal</surname><given-names>Anurag</given-names></name><role>Reviewing editor</role><aff><institution>Ashoka University</institution>, <country>India</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>Raquel.Granell@bristol.ac.uk</email> (RG);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>a.custovic@imperial.ac.uk</email> (AC);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>25</day><month>05</month><year>2023</year></pub-date><volume>12</volume><elocation-id>e84315</elocation-id><history><date date-type="received"><day>19</day><month>10</month><year>2022</year></date><date date-type="accepted"><day>22</day><month>05</month><year>2023</year></date></history><permissions><copyright-statement>Â© 2023, Granell et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Granell et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-84315-v1.pdf"/><abstract><sec><title>Background:</title><p>Many genes associated with asthma explain only a fraction of its heritability. Most genome-wide association studies (GWASs) used a broad definition of 'doctor-diagnosed asthma', thereby diluting genetic signals by not considering asthma heterogeneity. The objective of our study was to identify genetic associates of childhood wheezing phenotypes.</p></sec><sec><title>Methods:</title><p>We conducted a novel multivariate GWAS meta-analysis of wheezing phenotypes jointly derived using unbiased analysis of data collected from birth to 18 years in 9,568 individuals from five UK birth-cohorts.</p></sec><sec><title>Results:</title><p>44 independent SNPs were associated with early-onset persistent, 25 with preschool remitting, 33 with mid-childhood remitting and 32 with late-onset wheeze. We identified a novel locus on chr9q21.13 (close to annexin 1 (<italic>ANXA1</italic>), p&lt;6.7Ã10<sup>-9</sup>), associated exclusively with early-onset persistent wheeze. We identified rs75260654 as the most likely causative single nucleotide polymorphism (SNP) using Promoter Capture Hi-C loops, and then showed that the risk allele (T) confers a reduction in <italic>ANXA1</italic> expression. Finally, in a murine model of house dust mite (HDM)-induced allergic airway disease, we demonstrated that anxa1 protein expression increased and anxa1 mRNA was significantly induced in lung tissue following HDM exposure. Using anxa1<sup>-/-</sup> deficient mice, we showed that loss of anxa1 results in heightened airway hyperreactivity and Th2 inflammation upon allergen challenge.</p></sec><sec><title>Conclusions:</title><p>Targeting this pathway in persistent disease may represent an exciting therapeutic prospect.</p></sec><sec><title>Funding:</title><p>UK Medical Research Council Programme Grant MR/S025340/1 and the Wellcome Trust Strategic Award (108,818/15/Z) provided most of the funding for this study.</p></sec></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>UK Medical Research Council</institution></institution-wrap></funding-source><award-id>MR/S025340/1</award-id><principal-award-recipient><name><surname>Granell</surname><given-names>Raquel</given-names></name><name><surname>Custovic</surname><given-names>Adnan</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome Trust</institution></institution-wrap></funding-source><award-id>108818/15/Z</award-id><principal-award-recipient><name><surname>Granell</surname><given-names>Raquel</given-names></name><name><surname>Custovic</surname><given-names>Adnan</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Graham C Roberts, MRC grant to my institutionPresident of the British Society of Allergy and Clinical Immunology.</p></fn><fn fn-type="conflict" id="conf3"><p>Gerard H Koppelman, Dutch Lung Foundation, Ubbo Emmius Foundation (Money to insititution)Dutch Lung Foundation, Vertex, TEVA the Netherlands, GSK, ZON-MW (VICI grant), European Union (Money to institution)Astra Zeneca, Pure IMS, GSK (Money to institution)Sanofi, Boehringer Ingelheim (Money to institution).</p></fn><fn fn-type="conflict" id="conf4"><p>Angela Simpson, Medical research council Research grantJP Moulton Charitable Foundation Research grantAsthma UK Research grant.</p></fn><fn fn-type="conflict" id="conf5"><p>Clare S Murray, has received grants from Asthma Uk, the National Institute for Health Research, the Moulton Charitable Foundation and the North West Lung Centre Charity (to the Institution). They received lecture fees from GSK and Novartis, and received a travel grant from Sanofi. The authors has no other competing interests to declare..</p></fn><fn fn-type="conflict" id="conf6"><p>Clare M Lloyd, Wellcome Trust 107059/Z/15/Z.</p></fn><fn fn-type="conflict" id="conf7"><p>John W Holloway, Medial Research Council grant MR/S025340/1 (to institution)American Academy of Allergy Asthma and Immunology (AAAI) (Support for speaker travel to AAAAI annual congress ).</p></fn><fn fn-type="conflict" id="conf8"><p>Adnan Custovic, MRC (research grants)EPSRC (research grant)Wellcome Trust (research grant)Worg Pharmaceoticals (Personal payment &lt;US$5000)GSK Honorarium for lecture, personal, &lt;US$ 5000AstraZenecaHonorarium for lecture, personal, &lt;US$ 5000Sanofi Honorarium for lecture, personal, &lt;US$ 5000Stallergens-Greer Honorarium for lecture, personal, &lt;US$ 5000WAO (Board of officers, unpaid).</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: In accordance with the Animals (scientific procedures) act 1986, all animal experiments were conducted under the approved UK Home Office Project License No: PPL 70/7643, reviewed by Imperial College's Animal Welfare and Ethical Review body.</p></fn><fn fn-type="other"><p>Human subjects: ALSPAC: Ethical approval for the study was obtained from the ALSPAC Ethics and Law Committee and the Local Research Ethics Committees. Informed consent for the use of data collected via questionnaires and clinics was obtained from participants following the recommendations of the ALSPAC Ethics and Law Committee at the time. All self-completion questionnaire content is approved by the ALSPAC Ethics and Law Committee. Bristol and Weston Health Authority: E1808 Children of the Nineties: Avon Longitudinal Study of Pregnancy and Childhood (ALSPAC). (28th November 1989); Southmead Health Authority: 49/89 Children of the Nineties -&quot;ALSPAC&quot;. (5th April 1990); Frenchay Health Authority: 90/8 Children of the Nineties. (28th June 1990).MAAS: The study was approved by the North West - Greater Manchester East Research Ethics Committee. ERP/94/032 Up to 5 yrs. Allergen avoidance, Primary Prevention, genetics, sRaw age 3 and 5; SOU/00/259 5 year; ERP/95/137 Exposure to pet allergens, atopy, genetics; ERP/97/023 IFWIN, genetics; 03/SM/400 8 year; 06/Q1403/142 10-12 years; 11/NW/0228 13-15 years; 14/NW/1309 18+ years.SEATON: The study was approved by the North of Scotland Research Ethics Committee. REC reference: 13/NS/0108; Protocol number: 2/048/13; Amendment number: AM03.Ashford: The Asthma in Ashford study was reviewed by the Imperial College Research Ethics Committee on 11/11/2014. On 08/01/2015 the Joint Research Compliance Office granted full approval of the study on the basis described in the revised documents. ICREC reference: 14|C2288.IOW: Ethics approval for the IoW cohort was originally given by the Isle of Wight local research ethics committee in 1989 and at each subsequent follow up (1,2 and 4 years) (this is pre &quot;numbers&quot;)Age 10 follow up (including DNA and genotyping): Isle of Wight Health Authority Local Research Ethics Committee 18/98. Age 18 Follow up(including DNA and genotyping):  Isle of Wight, Portsmouth &amp; South East Hampshire Research Ethics Committee 06/Q1701/34.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>The informed consent obtained from all included participants does not allow the data to be made freely available through any third party maintained public repository.However, data used for this submission can be made available on request to the corresponding cohort Executive. Researchers will need to submit a research proposal to each cohort Executive Committee. Data access will have a cost, for more details re. ALSPAC contact alspac-data@bristol.ac.uk, for any other cohort contact philip.couch@manchester.ac.uk.The  ALSPAC website provides information on how to request and access its data ( http://www.bristol.ac.uk/alspac/researchers/access/). For queries regarding access of data from MAAS, IoW, SEATON or Ashford please contact Philip Couch philip.couch@manchester.ac.uk). All code used to analyse the individual level data and all summary data and code used to plot the figures in our manuscript has been deposited in Dryad.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Granell R</collab></person-group><year iso-8601-date="2023">2023</year><source>A meta-analysis of genome-wide association studies of childhood wheezing phenotypes identifies ANXA1 as a susceptibility locus for persistent wheezing (GWAS ANXA1)</source><ext-link ext-link-type="uri" xlink:href="https://dx.doi.org/10.5061/dryad.3r2280gm3">https://dx.doi.org/10.5061/dryad.3r2280gm3</ext-link><comment>Dryad Digital Repository, doi:10.5061/dryad.3r2280gm3</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-84315-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>